Host: |
Mouse |
Applications: |
ELISA |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Mouse monoclonal antibody anti-Lp-PLA2 is suitable for use in ELISA research applications. |
Clonality: |
Monoclonal |
Clone ID: |
11209 |
Conjugation: |
Unconjugated |
Isotype: |
IgG1 |
Formulation: |
50 mM Na-citrate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
Purification: |
Greater than 95% purity |
Concentration: |
5.0 mg/ml (+/-10 %) |
Storage Instruction: |
Unspecified, storage at 2–8°C. Temperature analysis:-70 °C, 21 days Not Determined (N/D)-20 °C, 14 days OK +4 °C, 14 days OK +35 °C, 14 days OK +45 °C, 7 days OK. Shelf life stability testing at 2–8 °C in the product buffer. |
Association Rate Constant: |
2.1 x 106 1/Ms |
Determination Method: |
SPR analysis (ProteOn XPR36) |
Immunoreactivity: |
80–120 % compared to the reference sample in an FIA test |
Immunogen: |
Human lipoprotein-associated phospholipase A2 |
Background | Lipoprotein-associated phospholipase A2 (Lp-PLA2) also known as platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme involved in atherosclerosis related vascular inflammation. Increased Lp-PLA2 mass and activity are prognostic biomarkers for cardiovascular disease (CVD) including coronary heart disease and ishcemic stroke. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance